Deltex Medical Group plc（DTXMF）· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。

FMP · DTXMF · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income

Breakdown	2024-12	2023-12	2022-12	2021-12	2020-12
Revenue
Revenue	$2.06M	$1.78M	$2.48M	$2.26M	$2.40M
Cost of Revenue	$0.66M	$0.65M	$0.64M	$0.68M	$0.76M
Gross Profit	$1.40M	$1.13M	$1.84M	$1.57M	$1.64M
Gross Margin %(computed)	68.00%	63.34%	74.09%	69.72%	68.43%
Operating Expenses
R&D Expenses	$0.29M	$0.22M	$0.23M	$0.21M	$0.25M
G&A Expenses	$1.09M	$1.08M	$1.56M	$1.58M	$1.47M
Total Operating Expenses	$2.98M	$2.18M	$2.82M	$2.44M	$2.21M
Operating Income	($1.59M)	($1.05M)	($0.95M)	($0.81M)	($0.62M)
Operating Margin %(computed)	-77.14%	-59.23%	-38.15%	-35.64%	-25.94%
Interest Income	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M
Interest Expense	$0.00M	$0.23M	$0.20M	$0.17M	$0.17M
Income Before Tax	($1.80M)	($1.28M)	($1.15M)	($0.98M)	($0.79M)
Income Tax Expense	$0.00M	$0.00M	($0.00M)	($0.01M)	($0.01M)
Net Income	($1.80M)	($1.28M)	($1.15M)	($0.97M)	($0.79M)
Net Margin %(computed)	-87.40%	-72.18%	-46.13%	-42.76%	-32.74%
Per Share & EBITDA
EPS (Basic)	$-0.00	$-0.00	$-0.00	$-0.00	$-0.00
Wtd Avg Shares	1895.57M	1181.57M	685.49M	580.71M	526.45M
EBITDA	($0.81M)	($0.92M)	($0.82M)	($0.69M)	($0.48M)
EBITDA Margin %(computed)	-39.25%	-51.75%	-33.00%	-30.59%	-20.02%